AbCellera Biologics Inc.

NasdaqGS:ABCL

Sector

🤖 Technology

Industries

🤖 Artificial Intelligence (AI)

🧬 Biotechnology

💊 Pharmaceuticals

🔍 Research & Consulting

Location

Canada

Market Cap

USD 1.37 B

Share Price

USD 4.59

Avg Daily Volume

6,246,819

Change (1 day)

2.00%

Change (1 year)

75.19%

Change (YTD)

56.66%

AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -203.72 M

AbCellera Biologics Inc. EBITDA is USD -203.72 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 6.74% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -190.85 M, a 1,551.85% change year over year.
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -11.55 M, a -103.70% change year over year.
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 311.96 M, a -7.25% change year over year.
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 336.34 M.